Loading

Journal of Urology and Research

Spinal Anaesthesia for Endoscopic Urological Surgery: A Comparison of 2% Hyperbaric Prilocaine with 0,5% Hyperbaric Bupivacaine

Research Article | Open Access | Volume 3 | Issue 1

  • 1. Department of anesthesiology, University of La Sapienza, Italy
+ Show More - Show Less
Corresponding Authors
Francesco Cannata, Department of anesthesiology, Pain medicine and critical care, Policlinico UmbertoI, University of La Sapienza, Rome, Italy, Tel: 39-06-4997-4262
Abstract

Background and aims: Hyperbaric prilocaine is a short-acting local anaesthetic. The aim of this study is to compare the characteristics of subarachnoid block using hyperbaric prilocaine with that of bupivacaine in outpatients undergoing transurethral resection of bladder (T.U.R.B.).

Methods: In this prospective randomized controlled trial, 60 patients undergoing endoscopic urological surgery received subarachnoid anaesthesia with either 2% hyperbaric prilocaine 60 mg (Group P) or 0,5% hyperbaric bupivacaine 15 mg (Group B). Recovery time from motor block was defined as the primary outcome variable. Secondary outcomes considered were: onset of sensory and motor block and adverse events like hypotension, bradycardia, nausea, pruritus. Motor block was assessed using the Bromage scoring system. A global patient satisfaction score was also obtained using the five points Likert scale.

Results: Onset time of sensory and motor block was faster in the group that received prilocaine. The duration of sensory block was also shorter in the prilocaine. Time to full motor function recovery was shorter after prilocaine than bupivacaine. Incidence of side effects like hypotension and bradicardia was significantly higher in bupivacaine group.

Conclusion: This study demostrated that intrathecal prilocaineis an alternative with a favourable recovery profile for use intransurethral resection of bladder.

Keywords

Spinal anaesthesia; Bupivacaine; Prilocaine; Urological surgery

Citation

Cannata F, Costantini M, Spinoglio A, Canneti A, Luzi M, et al. (2016) Spinal Anaesthesia for Endoscopic Urological Surgery: A Comparison of 2% Hyperbaric Prilocaine with 0,5% Hyperbaric Bupivacaine. J Urol Res 3(1): 1042.

ABBREVIATIONS

TNS: Transient Neurological Syndrome; TURB: Transurethral Resection of Bladder

INTRODUCTION

Spinal anesthesia (SA) is the most commonly used anesthetic technique for transurethral resection of bladder (TURB), which is reported to preserve cerebral function. Spinal anaesthesia for TURB provides excellent intraoperative analgesia, muscular relaxation, rapid onset of action, allows earlier determination of hyponatremia due to absorption of bladder irrigation fluids and reduces the possible hemodynamic and pulmonary adverse effects [1].

Spinal anaesthesia with short-acting local anaesthetics such as lidocaine and prilocaine can provide short times to discharge. However the association of lidocaine with transient neurologic symptoms (TNS) has limited the use of these agents in spinal anaesthesia. TNS was defined as pain or dysaesthesia in the buttocks, thighs, or lower limbs occurring after recovery from the anaesthetic and outside the surgical area. Bupivacaine is safe with a very low incidence of associated TNS, but the prolonged sensory and motor blocks are a disadvantage for a short procedure that requires a faster recovery of motor function. Prilocaine has a similar potency and duration of action to lidocaine and also has been reported to have a lower incidence of TNS [2].

The purpose of this study is to compare intrathecal prilocaine and bupivacaine for transurethral resection of bladder. The primary outcome is recovery time from motor block. Secondary outcomes considered are: onset of sensory and motor block and adverse events like hypotension, bradycardia, nausea, pruritus.

MATERIALS AND METHODS

In this prospective randomized controlled trial, 60 patients with ASA I, II, III status undergoing transurethral resection of bladder (TURB) were enrolled. Inclusion criteria were age between 18 and 70 yr, a height of 1.60–1.90 m, and a BMI of 18.5– 35 kg m−2. Exclusion criteria were

• Patients with ASA score >III

• Known allergy to any of the trial agents

• Patients in whom spinal anaesthesia was contraindicated and those patients in whom informed consent would not be possible.

Written informed consent was obtained from all patients.

A 16 gauge cannula was placed in all patients and they received a pre-filling with Ringer’s lactacte (500 ml)

All patients were premedicated with i.v midazolam 0,015 mg/Kg.

Patients were randomly allocated into the study groups according to the list of random numbers.

The study groups were as follows:

• GROUP B (N 30); patients assigned to this group received subarachnoid anaesthesia with 2% hyperbaric prilocaine

• GROUP P (N 30): in this group 0,5% hyperbaric bupivacaine (15 mg) was administered with spinal anaesthesia.

Spinal block was performed in lateral position at either L3-4 or L4-5 interspaces, using a 25 G whitacre spinal needle. After verifying free flow of clear cerebrospinal fluid, the prepared solution was injected into the intrathecal space in 15 seconds. The patients remained in this position for 2 minutes after the injection and were placed in the lithotomy position thereafter.

The highest dermatomal level of sensory block the time to reach this level and the motor blockade at the time of reaching highest dermatomal level of sensory block was recorded. Sensation block was checked using prin- prick test performed using a sterile needle. At 1 min intervals until the maximum block was achieved and at 15 min intervals thereafter until the block resolved.

Motor block was assessed by Bromage scores in which 0= no motor block, 1= hip blocked, 2= hip and knee blocked, 3= hip, knee and foot blocked. Patients were not put into litotomy position until the desired level of analgesia (T10) had been reached.

Blood pressure, heart rate, arterial oxygen saturation was registered during the procedure.

All patients were contacted at home by telephone on days 1 and 10 after surgery. A structured interview using a questionnaire was conducted about adverse effects like possible signs and symptoms of TNS. Recovery time from motor block was defined as the primary outcome variable. Secondary outcomes considered were: onset of sensory and motor block and adverse events like hypotension, bradycardia, nausea, pruritus,

A global patient satisfaction score (verbal) was also obtained, using the following Likert’s scale:

1. Very dissatisfied;

2. Slightly dissatisfied;

3. Neither satisfied nor dissatisfied;

4. Satisfied;

5. Highly satisfied.

Data on age, weight, height, and BMI are given as mean (SD). Other continuous variables are reported as median (range). Continuous variables such as onset and recovery time from sensory and motor block were compared using the Mann– Whitney U-test. This test was also used if the data were not normally distributed. In the case of other continuous numeric values, the groups were compared using the t-test. Non-continuous numeric values, such as block height at 30 and 90 min, are expressed as medians (range), and were tested with the Mann–Whitney U-test. Binominal data were compared using the χ2 or Fisher’s exact test.

RESULTS

Patients were enlisted in six months, none of them was excluded neither abandoned the study before it was conclused.

The ages (years); (Group P 67.6 ± 9; Group B 68.1 ± 7.8), Height (cm) (Group P 160.9 ± 9.1; Group B 165.8 ± 9.3), the weights (Kg); (Group P 68.6 ± 9; Group B 9 69.1 ± 7.1) and surgery duration (min) (Group P 41.2 ± 12.4; Group B 43.4 ± 13.6) in both groups were similar.

Onset time of sensory block was faster in the group P than B (mean 6, 7 min vs 13 min respectively, P<0.05). The two groups were comparable for the medians and the range of the maximum blocks after 30 min.

The median highest block level obtained in Group B was T9 and in Group P was T11. The total duration of sensory block was significantly shorter with prilocaine154 min (range 97–211) compared with bupivacaine 280 min (range 233–328 respectively, P<0.05) (Table 1).

Table 1:  Onset time and duration of sensory block in the two groups (median values):

 

Group P

Group B

Onset time of Sensory Block

6,7 min

13 min.

Duration of sensory block

99 min

257 min

*p < 0.05 Group B vs Group P.

The onset of motor block Bromage scale 3 was more rapid with prilocaine (P=0.020). Median time to complete regression of motor block was 99 min (range 80–117) with prilocaine compared with 257 min (range 205–310) with bupivacaine (P<0.05). In the prilocaine and bupivacaine groups, patients were discharged after 243 min (220–267) and 356 min (312– 401), respectively (P<0.05). The overall duration of motor block parameters was shorter in the prilocaine group and, notably, the difference in time until complete recovery was statistically significant (Table 2).

Table 2:  Onset time and duration of motor block in the two groups (median values):

 

Group P

Group B

Onset time of Motor Block

5,8min

9,5 min.

Duration of motor block

154 min

280 min

*p < 0.05 Group B vs Group P.

Motor blockade was significantly less important in patients receiving spinal prilocaine (median values for the Bromage scale at 2 in groups P, vs. 1 in Group B) (Figure 1).

Figure 1 Level of motor block evaluated with Bromage score.

Adverse effects during the procedure were shown in Table 3.

Table3: AdverseEffects in Groups.

 

Group B

(n = 30)

 

Group P

(n = 30)

 

Hypotension

6

0

Bradycardia

7

0

Pruritus

3

4

Nausea

1

5

Painduring procedure

0

0

Blockfailure

0

0

*p < 0.05 Group B vs Group P.

Hypotension was defined as a systolic blood pressure < 20% of preoperative value and bradycardia was defined as heart rate < 50 bpm. Four patients needed IV bolus ephedrine and 3 patients needed IV bolusatropine in Group B.

In Group B, hypotension was seen in 20% of patients (6 patients) and bradycardia was seen in 23% (7 patients) of patients. In none of the patients in Group P, hypotension and bradycardia were observed. These differences were significant between groups (p = 0.010, p = 0.021 respectively). Nausea was detected to a greater extent in Group P, this difference was not significant (p = 0.195). Other adverse effects were comparable in groups. None of the patients in either groups manifested block failure or pain during the procedure. All satisfaction scores (SSs) were recorded as either 4 or 5. In Group P, seven subjects gave an SS of 4 and 23 subjects gave an SS of 5. In Group B, 10 subjects gave an SS of 4 and 20 subjects gave an SS of 5. As all SSs were either 4 or 5, results were analysed using a χ2 test. Analysis did not demonstrate a significant difference in scores between the two groups (P=0.10). No patient in either group developed symptoms consistent with the occurrence of TNS.

DISCUSSION AND CONCLUSION

In literature, many different local anesthetics have been used in SA for TURB surgery. The most popular local anesthetic in day case surgical patients is lidocaine but high incidence of TNS after intrathecal lidocaine led to the search for an alternative to lidocaine [3]. The present study shows that prilocaine is an alternative to bupivacaine as a short-acting spinal anaesthetic. Prilocaine and bupivacaine produce a similar quality of spinal anaesthesia but hyperbaric prilocaine 60 mg resulted in significantly faster recovery from both motor and sensory block in comparison with hyperbaric bupivacaine 15 mg. Onset of both sensory and motor block are also faster [4].Recent data indicate that TNS may be less frequent after prilocaine-induced spinal anaesthesia [5].

Prilocaine has a similar potency and duration of action to lidocaine and has been reported to have a lower incidence of TNS [6]. Bupivacaine (4 mg) with 25 µg fentanyl was reported as providing adequate analgesia for TURP in the study of Kararmaz et al[7]. In this study, they compared this low-dose bupivacaine usage with the conventional dose of bupivacaine (7.5 mg) bupivacaine carries a low risk of TNS.

In our study the administration of hyperbaric prilocaine at 2% (60 mg) produced adequate analgesia comparable to that following administration of 15mg of bupivacaine at 0.5%. The significant difference between the two groups was the duration of sensory and motor block.

Onset of sensory block peak height was faster in Group P than in Group B.

A previous study, a comparison of low-dose prilocaine and fentanyl with bupivacaine and fentanyl, found a median peak sensory block height of T4, compared with T11 in our study [8]. It may be that the addition of fentanyl contributed to this difference. Regression of sensory and motor block has been argued to be a marker for the ability to void. They were much faster in the prilocaine group.

In our study hypotension and bradycardia were not observed in Group P; but hypotension was observed in 20% and bradycardia was observed in 23% of patients in Group B, which is significantly more than Group P.

A previous study compared the use of 40 mg and 60 mg hyperbaric prilocaine doses with 60 mg plain prilocaine in ambulatory surgery [9]. The authors reported that hyperbaric prilocaine is superior to plain prilocaine in the ambulatory setting in terms of faster time to motor block resolution and shorter durations of surgical block [10].

The incidence of TNS for both local anaesthetics was comparable during hospital admission and on days 1 and 10 post-discharge. The study population, however, was not large enough to discover any difference in the occurrence of rare sideeffects such as TNS. A much larger study would be required to quantify this. Of note is the occurrence of a rare case of TNS after prilocaine use, reported on day 10 post-discharge.

We conclude that spinal anaesthesia with 60 mg of hyperbaric prilocaine results in a shorter duration of action than a spinal anaesthesia with 15 mg of hyperbaric bupivacaine of approximately 1 h duration. Prilocaine is an alternative with a favourable recovery profile for use intransurethral resection of bladder.

REFERENCES
  1. Ostgaard G, Hallaråker O, Ulveseth OK, Flaatten H. A randomised study of lidocaine and prilocaine for spinal anaesthesia. Acta Anaesthesiol Scand. 2000; 44: 436-440.
  2. Zaric d, Pace NL. Transient neurologic symptoms (TNS) following spinal anaesthesia with lidocaine versus other local anaesthetics. Cochrane Database Syst Rev. 2009.
  3. Vagts DA, Bley CH, Mutz CW. [Use of 2 % hyperbaric prilocaine for spinal anesthesia : sensitivity analysis in outpatient surgery]. Anaesthesist. 2013; 62: 271-277.
  4. Roxas MF, Talip BN, Crisostomo AC. Double-blind, randomized, placebo-controlled trial to determine the efficacy of eutectic lidocaine/prilocaine (EMLA) cream for decreasing pain during local anaesthetic infiltration for out-patient haemorrhoidectomy. Asian J Surg. 2003; 26: 26-30.
  5. Kumar CM, Corbett WA, Wilson RG. Spinal anaesthesia with a micro-catheter in high-risk patients undergoing colorectal cancer and other major abdominal surgery. Surg Oncol. 2008; 17: 73-79.
  6. Pacella E, Pacella F, Troisi F, Dell'edera D, Tuchetti P, Lenzi T, et al. Efficacy and safety of 0.5% levobupivacaine versus 0.5% bupivacaine for peribulbar anesthesia. Clin Ophthalmol. 2013; 7: 927-932.
  7. Akcaboy Zn, AkcaboyEy, Mutlu Nm, Serger N, Aksu C, Gogus N. Spinal anesthesia with low-dose bupivacaine-fentanyl combination: a good      alternative for day case transurethral resection of prostrate surgery in geriatric patients. RevBrasAnestesiol. 2012; 62.
  8. Black AS, Newcombe GN, Plummer JL, McLeod DH, Martin DK. Spinal anaesthesia for ambulatory arthroscopic surgery of the knee: a comparison of low-dose prilocaine and fentanyl with bupivacaine and fentanyl.  Br J Anaesth. 2011; 106: 183-188.
  9. Manassero A, Bossolasco M, Ugues S, Bailo C, Liarou C, Coletta G. Comparison of unilateral and bilateral spinal anesthesia with 2% hyperbaric prilocaine in day-case inguinal herniorrhaphy: a randomized controlled trial.Minerva Anestesiol. 2014; 80: 685-691.
  10. Aguirre J, Borgeat A, Bühler P, Mrdjen J, Hardmeier B, Bonvini JM. Intrathecal hyperbaric 2% prilocaine versus 0.4% plain ropivacaine for same-day arthroscopic knee surgery: a prospective randomized double-blind controlled study. Can J Anaesth. 2015; 62: 1055-1062.

Cannata F, Costantini M, Spinoglio A, Canneti A, Luzi M, et al. (2016) Spinal Anaesthesia for Endoscopic Urological Surgery: A Comparison of 2% Hyperbaric Prilocaine with 0,5% Hyperbaric Bupivacaine. J Urol Res 3(1): 1042.

Received : 19 Nov 2015
Accepted : 19 Dec 2015
Published : 02 Jan 2016
Journals
Annals of Otolaryngology and Rhinology
ISSN : 2379-948X
Launched : 2014
JSM Schizophrenia
Launched : 2016
Journal of Nausea
Launched : 2020
JSM Internal Medicine
Launched : 2016
JSM Hepatitis
Launched : 2016
JSM Oro Facial Surgeries
ISSN : 2578-3211
Launched : 2016
Journal of Human Nutrition and Food Science
ISSN : 2333-6706
Launched : 2013
JSM Regenerative Medicine and Bioengineering
ISSN : 2379-0490
Launched : 2013
JSM Spine
ISSN : 2578-3181
Launched : 2016
Archives of Palliative Care
ISSN : 2573-1165
Launched : 2016
JSM Nutritional Disorders
ISSN : 2578-3203
Launched : 2017
Annals of Neurodegenerative Disorders
ISSN : 2476-2032
Launched : 2016
Journal of Fever
ISSN : 2641-7782
Launched : 2017
JSM Bone Marrow Research
ISSN : 2578-3351
Launched : 2016
JSM Mathematics and Statistics
ISSN : 2578-3173
Launched : 2014
Journal of Autoimmunity and Research
ISSN : 2573-1173
Launched : 2014
JSM Arthritis
ISSN : 2475-9155
Launched : 2016
JSM Head and Neck Cancer-Cases and Reviews
ISSN : 2573-1610
Launched : 2016
JSM General Surgery Cases and Images
ISSN : 2573-1564
Launched : 2016
JSM Anatomy and Physiology
ISSN : 2573-1262
Launched : 2016
JSM Dental Surgery
ISSN : 2573-1548
Launched : 2016
Annals of Emergency Surgery
ISSN : 2573-1017
Launched : 2016
Annals of Mens Health and Wellness
ISSN : 2641-7707
Launched : 2017
Journal of Preventive Medicine and Health Care
ISSN : 2576-0084
Launched : 2018
Journal of Chronic Diseases and Management
ISSN : 2573-1300
Launched : 2016
Annals of Vaccines and Immunization
ISSN : 2378-9379
Launched : 2014
JSM Heart Surgery Cases and Images
ISSN : 2578-3157
Launched : 2016
Annals of Reproductive Medicine and Treatment
ISSN : 2573-1092
Launched : 2016
JSM Brain Science
ISSN : 2573-1289
Launched : 2016
JSM Biomarkers
ISSN : 2578-3815
Launched : 2014
JSM Biology
ISSN : 2475-9392
Launched : 2016
Archives of Stem Cell and Research
ISSN : 2578-3580
Launched : 2014
Annals of Clinical and Medical Microbiology
ISSN : 2578-3629
Launched : 2014
JSM Pediatric Surgery
ISSN : 2578-3149
Launched : 2017
Journal of Memory Disorder and Rehabilitation
ISSN : 2578-319X
Launched : 2016
JSM Tropical Medicine and Research
ISSN : 2578-3165
Launched : 2016
JSM Head and Face Medicine
ISSN : 2578-3793
Launched : 2016
JSM Cardiothoracic Surgery
ISSN : 2573-1297
Launched : 2016
JSM Bone and Joint Diseases
ISSN : 2578-3351
Launched : 2017
JSM Bioavailability and Bioequivalence
ISSN : 2641-7812
Launched : 2017
JSM Atherosclerosis
ISSN : 2573-1270
Launched : 2016
Journal of Genitourinary Disorders
ISSN : 2641-7790
Launched : 2017
Journal of Fractures and Sprains
ISSN : 2578-3831
Launched : 2016
Journal of Autism and Epilepsy
ISSN : 2641-7774
Launched : 2016
Annals of Marine Biology and Research
ISSN : 2573-105X
Launched : 2014
JSM Health Education & Primary Health Care
ISSN : 2578-3777
Launched : 2016
JSM Communication Disorders
ISSN : 2578-3807
Launched : 2016
Annals of Musculoskeletal Disorders
ISSN : 2578-3599
Launched : 2016
Annals of Virology and Research
ISSN : 2573-1122
Launched : 2014
JSM Renal Medicine
ISSN : 2573-1637
Launched : 2016
Journal of Muscle Health
ISSN : 2578-3823
Launched : 2016
JSM Genetics and Genomics
ISSN : 2334-1823
Launched : 2013
JSM Anxiety and Depression
ISSN : 2475-9139
Launched : 2016
Clinical Journal of Heart Diseases
ISSN : 2641-7766
Launched : 2016
Annals of Medicinal Chemistry and Research
ISSN : 2378-9336
Launched : 2014
JSM Pain and Management
ISSN : 2578-3378
Launched : 2016
JSM Women's Health
ISSN : 2578-3696
Launched : 2016
Clinical Research in HIV or AIDS
ISSN : 2374-0094
Launched : 2013
Journal of Endocrinology, Diabetes and Obesity
ISSN : 2333-6692
Launched : 2013
Journal of Substance Abuse and Alcoholism
ISSN : 2373-9363
Launched : 2013
JSM Neurosurgery and Spine
ISSN : 2373-9479
Launched : 2013
Journal of Liver and Clinical Research
ISSN : 2379-0830
Launched : 2014
Journal of Drug Design and Research
ISSN : 2379-089X
Launched : 2014
JSM Clinical Oncology and Research
ISSN : 2373-938X
Launched : 2013
JSM Bioinformatics, Genomics and Proteomics
ISSN : 2576-1102
Launched : 2014
JSM Chemistry
ISSN : 2334-1831
Launched : 2013
Journal of Trauma and Care
ISSN : 2573-1246
Launched : 2014
JSM Surgical Oncology and Research
ISSN : 2578-3688
Launched : 2016
Annals of Food Processing and Preservation
ISSN : 2573-1033
Launched : 2016
Journal of Radiology and Radiation Therapy
ISSN : 2333-7095
Launched : 2013
JSM Physical Medicine and Rehabilitation
ISSN : 2578-3572
Launched : 2016
Annals of Clinical Pathology
ISSN : 2373-9282
Launched : 2013
Annals of Cardiovascular Diseases
ISSN : 2641-7731
Launched : 2016
Journal of Behavior
ISSN : 2576-0076
Launched : 2016
Annals of Clinical and Experimental Metabolism
ISSN : 2572-2492
Launched : 2016
Clinical Research in Infectious Diseases
ISSN : 2379-0636
Launched : 2013
JSM Microbiology
ISSN : 2333-6455
Launched : 2013
Journal of Family Medicine and Community Health
ISSN : 2379-0547
Launched : 2013
Annals of Pregnancy and Care
ISSN : 2578-336X
Launched : 2017
JSM Cell and Developmental Biology
ISSN : 2379-061X
Launched : 2013
Annals of Aquaculture and Research
ISSN : 2379-0881
Launched : 2014
Clinical Research in Pulmonology
ISSN : 2333-6625
Launched : 2013
Journal of Immunology and Clinical Research
ISSN : 2333-6714
Launched : 2013
Annals of Forensic Research and Analysis
ISSN : 2378-9476
Launched : 2014
JSM Biochemistry and Molecular Biology
ISSN : 2333-7109
Launched : 2013
Annals of Breast Cancer Research
ISSN : 2641-7685
Launched : 2016
Annals of Gerontology and Geriatric Research
ISSN : 2378-9409
Launched : 2014
Journal of Sleep Medicine and Disorders
ISSN : 2379-0822
Launched : 2014
JSM Burns and Trauma
ISSN : 2475-9406
Launched : 2016
Chemical Engineering and Process Techniques
ISSN : 2333-6633
Launched : 2013
Annals of Clinical Cytology and Pathology
ISSN : 2475-9430
Launched : 2014
JSM Allergy and Asthma
ISSN : 2573-1254
Launched : 2016
Journal of Neurological Disorders and Stroke
ISSN : 2334-2307
Launched : 2013
Annals of Sports Medicine and Research
ISSN : 2379-0571
Launched : 2014
JSM Sexual Medicine
ISSN : 2578-3718
Launched : 2016
Annals of Vascular Medicine and Research
ISSN : 2378-9344
Launched : 2014
JSM Biotechnology and Biomedical Engineering
ISSN : 2333-7117
Launched : 2013
Journal of Hematology and Transfusion
ISSN : 2333-6684
Launched : 2013
JSM Environmental Science and Ecology
ISSN : 2333-7141
Launched : 2013
Journal of Cardiology and Clinical Research
ISSN : 2333-6676
Launched : 2013
JSM Nanotechnology and Nanomedicine
ISSN : 2334-1815
Launched : 2013
Journal of Ear, Nose and Throat Disorders
ISSN : 2475-9473
Launched : 2016
JSM Ophthalmology
ISSN : 2333-6447
Launched : 2013
Journal of Pharmacology and Clinical Toxicology
ISSN : 2333-7079
Launched : 2013
Annals of Psychiatry and Mental Health
ISSN : 2374-0124
Launched : 2013
Medical Journal of Obstetrics and Gynecology
ISSN : 2333-6439
Launched : 2013
Annals of Pediatrics and Child Health
ISSN : 2373-9312
Launched : 2013
JSM Clinical Pharmaceutics
ISSN : 2379-9498
Launched : 2014
JSM Foot and Ankle
ISSN : 2475-9112
Launched : 2016
JSM Alzheimer's Disease and Related Dementia
ISSN : 2378-9565
Launched : 2014
Journal of Addiction Medicine and Therapy
ISSN : 2333-665X
Launched : 2013
Journal of Veterinary Medicine and Research
ISSN : 2378-931X
Launched : 2013
Annals of Public Health and Research
ISSN : 2378-9328
Launched : 2014
Annals of Orthopedics and Rheumatology
ISSN : 2373-9290
Launched : 2013
Journal of Clinical Nephrology and Research
ISSN : 2379-0652
Launched : 2014
Annals of Community Medicine and Practice
ISSN : 2475-9465
Launched : 2014
Annals of Biometrics and Biostatistics
ISSN : 2374-0116
Launched : 2013
JSM Clinical Case Reports
ISSN : 2373-9819
Launched : 2013
Journal of Cancer Biology and Research
ISSN : 2373-9436
Launched : 2013
Journal of Surgery and Transplantation Science
ISSN : 2379-0911
Launched : 2013
Journal of Dermatology and Clinical Research
ISSN : 2373-9371
Launched : 2013
JSM Gastroenterology and Hepatology
ISSN : 2373-9487
Launched : 2013
Annals of Nursing and Practice
ISSN : 2379-9501
Launched : 2014
JSM Dentistry
ISSN : 2333-7133
Launched : 2013
Author Information X